In September, IBM (NYSE:IBM) was downplaying expectations for its big data business. No longer. Big Blue this week showed analysts what its Watson supercomputer is capable of in a demonstration at the company's Almaden Research Center outside of San Jose, Calif.
Big Blue believes that, by putting Watson to work on data-intensive tasks such as drug development, the company will corner at least part of the big data market opportunity before peers Teradata (NYSE:TDC) and Oracle (NYSE:ORCL) can get there. Both companies sell finely honed database systems.
For IBM, Watson could help IBM unlock $16 billion in big data revenue by 2015, The New York Times reports, making its supercomputer the world's most valuable consultant. What are the odds of success? Is now the time to bet on Big Blue? Tim Beyers of Motley Fool Rule Breakers and Motley Fool Supernova addresses these questions and more in the video below. Please watch, and then be sure to leave a comment to let us know what you think.